Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.54 USD
Change Today +0.019 / 3.65%
Volume 1.2M
STEM On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Martin M. McGlynn

Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc,StemCells Inc.
AgeTotal Calculated CompensationThis person is connected to 8 board members in 1 different organizations across 1 different industries.

See Board Relationships
69$832,784
As of Fiscal Year 2014

Background*

Mr. Martin M. McGlynn has been the Chief Executive Officer of Stemcells Inc. and of its wholly-owned subsidiary, StemCells California, Inc. since January 15, 2001. Mr. McGlynn joined Stemcells Inc. in January 15, 2001. He served as the President of Stemcells Inc. from January 15, 2001 to March 24, 2015. He began his career with Becton Dickinson, Ireland Ltd., and spent 8 years in manufacturing operations. He has been Secretary of Alliance for Regenerative Medicine since ...

Read Full Background

Corporate Headquarters*

7707 Gateway Boulevard
Newark, California 94560

United States

Phone: 510-456-4000
Fax: 510-456-4001

Board Members Memberships*

2001-Present
Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc

Education*

Bachelor's Degree 1968
University College Dublin

Other Affiliations*

Annual Compensation*

Salary$570,000
Bonus$219,450
Total Annual Compensation$789,450

Stock Options*

All Other Compensation$43,334
Exercisable Options30,000
Total Number of Options30,000

Total Compensation*

Total Annual Cash Compensation$832,784
Total Short Term Compensation$789,450
Other Long Term Compensation$43,334
Total Calculated Compensation$832,784
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STEM:US $0.54 USD +0.019

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$599.8K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$437.4K
Mike Tomas Chief Executive Officer, President, Chief Financial Officer, Director and Member of Advisory Board
Bioheart, Inc.
$1.3M
Neil K. Warma Chief Executive Officer, President and Director
Opexa Therapeutics, Inc.
$579.2K
Mark R. Weinreb M.S.Chairman, Chief Executive Officer and President
BioRestorative Therapies, Inc.
$675.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STEMCELLS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.